[1]
“CLINICAL FEATURES OF BEHAVIORAL DISORDERS RELATING TO AMPHETAMINE TYPE SUBSTANCES USE”, YHCĐ, vol. 62, no. 1 (2021), Nov. 2020, doi: 10.52163/yhc.v62i1 (2021).12.